World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
54
Citations
13070
World Ranking
3865
National Ranking
339

Ruth F. Jarrett publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ruth F. Jarrett sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 165 publications — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ruth F. Jarrett D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ruth F. Jarrett sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 54 D-Index — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2007 - Fellow of the Royal Society of Edinburgh

Overview

Ruth F. Jarrett is affiliated with the University of Glasgow in the United Kingdom. Their primary research focus lies within the field of Medicine, with significant emphasis on Infectious Diseases, Pathology and Forensic Medicine, Oncology, Molecular Biology, and Genetics. This diverse subfield expertise supports a concentrated investigation into both viral diseases and cancer-related topics.

The scientist has contributed extensively to topics including:

  • Lymphoma Diagnosis and Treatment
  • SARS-CoV-2 and COVID-19 Research
  • Viral-associated cancers and disorders
  • COVID-19 Clinical Research Studies
  • COVID-19 epidemiological studies
  • Animal Virus Infections Studies
  • Virus-based gene therapy research

Jarrett's research output spans a variety of publication venues, with multiple contributions in the following journals and repositories:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cell
  • Veterinary Record
  • Leukemia
  • Journal of Virology

Among the recent papers authored or co-authored by Jarrett are:

  • Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity, 2020, Cell
  • Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity, 2021, Cell
  • A prenylated dsRNA sensor protects against severe COVID-19, 2021, Science
  • Evaluating the effects of SARS-CoV-2 Spike mutation D614G on transmissibility and pathogenicity, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity, 2020, bioRxiv (Cold Spring Harbor Laboratory)

Frequent co-authors in their work include:

  • David L. Robertson
  • Henrik Hjalgrim
  • Karin E. Smedby
  • Ana da Silva Filipe
  • Vanessa Herder

In recognition of contributions to their field, Ruth F. Jarrett was awarded the title of Fellow of the Royal Society of Edinburgh in 2007.

Best Publications

  • Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity.

    Erik Volz;Verity Hill;John T McCrone;Anna Price

  • Human Tissues Contain CD141hi Cross-Presenting Dendritic Cells with Functional Homology to Mouse CD103+ Nonlymphoid Dendritic Cells

    Muzlifah Haniffa;Muzlifah Haniffa;Amanda Shin;Venetia Bigley;Naomi McGovern

  • HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA

    Mark B. Feinberg;Ruth F. Jarrett;Anna Aldovini;Robert C. Gallo

  • Epstein‐Barr virus‐associated Hodgkin's disease: Epidemiologic characteristics in international data

    Sally L. Glaser;Ruby J. Lin;Susan L. Stewart;Richard F. Ambinder

  • Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.

    Emma C. Thomson;Emma C. Thomson;Laura E. Rosen;James G. Shepherd;Roberto Spreafico

  • Evaluating the effects of SARS-CoV-2 Spike mutation D614G on transmissibility and pathogenicity

    Erik M Volz;Verity Hill;John T McCrone;Anna Price

  • Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha.

    Eric Cabannes;Gulfaraz Khan;Fabienne Aillet;Ruth F Jarrett

  • Isolation of human lymphotropic herpesviruses from Uganda.

    R.G. Downing;N. Sewankambo;D. Serwadda;R. Honess

  • Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro

    H Mitsuya;R F Jarrett;M Matsukura;F Di Marzo Veronese

  • Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study.

    Ruth F. Jarrett;Gail L. Stark;Jo White;Brian Angus

  • A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 ( REL ), 8q24.21 and 10p14 ( GATA3 )

    Victor Enciso-Mora;Peter Broderick;Yussanne Ma;Ruth F. Jarrett

  • Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age.

    R F Jarrett;A Gallagher;D B Jones;F E Alexander

  • Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents.

    F E Alexander;R F Jarrett;D Lawrence;A A Armstrong

  • HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma.

    Marijke Niens;Ruth F. Jarrett;Bouke Hepkema;Ilja M. Nolte

  • Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups

    Kevin Y. Urayama;Ruth F. Jarrett;Henrik Hjalgrim;Arjan Diepstra

  • Epstein-Barr virus and Hodgkin's disease : further evidence for the three disease hypothesis

    AA Armstrong;FE Alexander;R Cartwright;B Angus

  • Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease

    Alice Gallagher;Alison A. Armstrong;Jane MacKenzie;Lesley Shield

  • Detection of human herpesvirus-6 DNA in peripheral blood and saliva.

    Ruth F. Jarrett;Duncan A. Clark;Steven F. Josephs;David E. Onions

  • Viruses and Hodgkin's lymphoma

    R. F. Jarrett

  • Prevalence of Antibody to Human Herpesvirus 7 by Age

    Clark Da;Freeland Ml;Mackie Lk;Jarrett Rf

Frequent Co-Authors

Henrik Hjalgrim
Henrik Hjalgrim Statens Serum Institut
Hans-Olov Adami
Hans-Olov Adami Karolinska Institute
Mads Melbye
Mads Melbye University of Copenhagen
Anke van den Berg
Anke van den Berg University Medical Center Groningen
Eve Roman
Eve Roman University of York
Karin E. Smedby
Karin E. Smedby Karolinska University Hospital
Bengt Glimelius
Bengt Glimelius Uppsala University
David Robertson
David Robertson Vanderbilt University
Wendy Cozen
Wendy Cozen University of Southern California
Ilja M. Nolte
Ilja M. Nolte University Medical Center Groningen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, expanding into healthcare roles like psychiatric nursing or advanced practice nursing can be a natural progression. Many students explore obtaining a Doctor of Nursing Practice (DNP) degree, which often leads to higher earning potential and leadership opportunities in clinical settings.

When considering further education, it's important to find programs that offer strong clinical experiences. The best pmhnp programs stand out for their exceptional clinical placement rates, helping students gain critical hands-on skills. For those mindful of budget constraints, reviewing affordable pmhnp programs can make advanced education more accessible without sacrificing quality.

Understanding the financial rewards of advanced nursing degrees is also crucial. The dnp salary varies by location and specialization, but overall it reflects the demand and responsibility of these roles.

For registered nurses interested in specializing further, bridge programs like the fnp to acute care np bridge program offer a clear pathway to transition into acute care, expanding clinical scope and career options.

Best Scientists Citing Ruth F. Jarrett

Trending Scientists

Recently Published Articles